Clinical trials
Recruiting Carcinoma, Transitional Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 14 |
| 2025 | 17 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 73 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Fox Chase Cancer Center | 3 |
| Mayo Clinic | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Astellas Pharma Global Development, Inc. | 2 |
| Daiichi Sankyo | 2 |
| Dana-Farber Cancer Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| Pfizer | 2 |
| University of California, Irvine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 73 |
| Urinary Bladder Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Carcinoma, Renal Cell | 18 |
| Uterine Cervical Neoplasms | 14 |
| Colorectal Neoplasms | 13 |
| Melanoma | 13 |
| Ovarian Neoplasms | 13 |
| Squamous Cell Carcinoma of Head and Neck | 13 |
| Endometrial Neoplasms | 10 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.